Corvus Pharmaceuticals (CRVS) Shares Outstanding: 2022-2025
Historic Shares Outstanding for Corvus Pharmaceuticals (CRVS) over the last 4 years, with Sep 2025 value amounting to $74.7 million.
- Corvus Pharmaceuticals' Shares Outstanding rose 19.34% to $74.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.7 million, marking a year-over-year increase of 19.34%. This contributed to the annual value of $67.9 million for FY2024, which is 38.46% up from last year.
- According to the latest figures from Q3 2025, Corvus Pharmaceuticals' Shares Outstanding is $74.7 million, which was up 0.23% from $74.5 million recorded in Q2 2025.
- In the past 5 years, Corvus Pharmaceuticals' Shares Outstanding ranged from a high of $74.7 million in Q3 2025 and a low of $46.6 million during Q1 2022.
- In the last 3 years, Corvus Pharmaceuticals' Shares Outstanding had a median value of $62.6 million in 2024 and averaged $59.4 million.
- Data for Corvus Pharmaceuticals' Shares Outstanding shows a peak YoY spiked of 39.01% (in 2025) over the last 5 years.
- Quarterly analysis of 4 years shows Corvus Pharmaceuticals' Shares Outstanding stood at $46.6 million in 2022, then climbed by 5.34% to $49.0 million in 2023, then spiked by 38.46% to $67.9 million in 2024, then rose by 19.34% to $74.7 million in 2025.
- Its Shares Outstanding was $74.7 million in Q3 2025, compared to $74.5 million in Q2 2025 and $68.2 million in Q1 2025.